Olli Kampman

Professor of Psychiatry, Senior Consultant at Region Västerbotten

Legalized Psychotherapist (cognitive behavioural therapy)

0000-0001-6891-2266

Contact

olli.kampman@umu.se

Works at

Professor, senior consultant (attending) physician at Department of Clinical Sciences Section: Psychiatry

Visiting address, view map

Professor Olli Kampman is a clinical psychiatrist and an active scientist for 30 years back. He has started as the Professor of Psychiatry at the Umeå University in autumn 2022. He is also a Professor of Psychiatry at the University of Turku, in Vaasa Central Hospital.

His >100 peer reviewed international scientific publications cover the following subjects that are also his main topics of interest. He is a qualified supervisor of PhD students with so far, a dozen finalised PhD theses.

Topics of interest:

Pharmacogenetics in Psychiatry

Inflammatory Processes in Psychiatric Disorders

Compliance and Treatment Adherence in Psychoses

Dual diagnosis in Psychiatry

Antipsychotic medications and sleep problems in patients with schizophrenia

Schizophrenia Research, Elsevier 2024, Vol. 267 : 230-238

Cederlöf, Erik; Holm, Minna; Taipale, Heidi; et al.

Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders

Molecular Psychiatry, Springer Nature 2024, Vol. 29, (9) : 2733-2741

Kämpe, Anders; Suvisaari, Jaana; Lahteenvuo, Markku; et al.

Association of somatic comorbidity and treatment adherence in patients with psychotic disorder

Journal of Psychiatric Research, Elsevier 2024, Vol. 174 : 1-7

Leijala, J.; Kampman, Olli; Suvisaari, J.; et al.

Socioeconomic status, psychotherapy duration, and return to work from disability due to common mental disorders

Psychotherapy Research, Routledge 2024, Vol. 34, (5) : 694-707

Leppänen, Helena; Kampman, Olli; Autio, Reija; et al.

Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia

Schizophrenia Research, Elsevier 2024, Vol. 266 : 118-126

Mäkipelto, Ville; Tuulio-Henriksson, Annamari; Hakulinen, Christian; et al.

High burden of ileus and pneumonia in clozapine-treated individuals with schizophrenia: a Finnish 25-year follow-up register study

American Journal of Psychiatry, American Psychiatric Association Publishing 2024, Vol. 181, (10) : 879-892

Partanen, Juulia J.; Häppölä, Paavo; Kämpe, Anders; et al.

Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients

Acta Neuropsychiatrica, Cambridge University Press 2024, Vol. 36, (4) : 218-223

Puolakka, Hanna; Solismaa, Anssi; Lyytikäinen, Leo-Pekka; et al.

Genetic risk scores associated with temperament clusters in Finnish depression patients

Acta Neuropsychiatrica, Cambridge University Press 2024, Vol. 36, (1) : 51-59

Salminen, Simo-Pekko; Solismaa, Anssi; Lyytikäinen, Leo-Pekka; et al.

A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample

Acta Neuropsychiatrica

Sandstrom, Karl; Kampman, Olli; Asellus, Peter

Geographical variation in treated psychotic and other mental disorders in Finland by region and urbanicity

Social Psychiatry and Psychiatric Epidemiology, Springer 2024, Vol. 59 : 37-49

Suokas, Kimmo; Kurkela, Olli; Nevalainen, Jaakko; et al.

Association of obesity to reaction time and visual memory in schizophrenia

Schizophrenia Research: Cognition, Elsevier 2024, Vol. 37

Toimela, J.S.; Halt, A.H.; Kerkelä, M.; et al.

Functional characterization of six SLCO1B1 (OATP1B1) variants observed in Finnish individuals with a psychotic disorder

Molecular Pharmaceutics, American Chemical Society (ACS) 2023, Vol. 20, (3) : 1500-1508

Häkkinen, Katja; Kiander, Wilma; Kidron, Heidi; et al.

Machine learning classification of psychiatric data associated with compensation claims for patient injuries

Methods of Information in Medicine, Georg Thieme Verlag KG 2023, Vol. 62, (05/06) : 174-182

Juhola, Martti; Nikkanen, Tommi; Niemi, Juho; et al.

Predictors of short-term response and the role of heavy alcohol use in treatment of depression

BMC Psychiatry, BioMed Central (BMC) 2023, Vol. 23, (1)

Luoto, Kaisa E.; Lassila, Antero; Leinonen, Esa; et al.

Cohort profile: SUPER-Finland - the Finnish study for hereditary mechanisms of psychotic disorders

BMJ Open, BMJ Publishing Group Ltd 2023, Vol. 13, (4)

Lähteenvuo, Markku; Ahola-Olli, Ari; Suokas, Kimmo; et al.

Differences in psychosocial functioning between psychotic disorders in the Finnish SUPER study

Schizophrenia Research, Elsevier 2022, Vol. 244 : 10-17

Ahti, Johan; Kieseppä, Tuula; Suvisaari, Jaana; et al.

The role of alcohol use and adiposity in serum levels of IL-1RA in depressed patients

BMC Psychiatry, BioMed Central (BMC) 2022, Vol. 22, (1)

Archer, Mari; Niemelä, Onni; Hämäläinen, Mari; et al.

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder

The Pharmacogenomics Journal, Springer Nature 2022, Vol. 22, (3) : 166-172

Häkkinen, Katja; Kiiski, Johanna I.; Lähteenvuo, Markku; et al.

Adverse childhood experiences and social and occupational functioning in first-episode psychosis: a one year follow - up

Psychiatry Research, Elsevier 2022, Vol. 311

Kemppainen, Anniina; Lindgren, Maija; Suvisaari, Jaana; et al.

Socioeconomic factors and use of psychotherapy in common mental disorders predisposing to disability pension

BMC Health Services Research, BioMed Central (BMC) 2022, Vol. 22, (1)

Leppänen, Helena; Kampman, Olli; Autio, Reija; et al.

Mortality in persons with recent primary or secondary care contacts for mental disorders in Finland

World Psychiatry, John Wiley & Sons 2022, Vol. 21, (3) : 470-471

Suokas, Kimmo; Hakulinen, Christian; Sund, Reijo; et al.

Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine

Psychiatry Research, Elsevier 2021, Vol. 306

Klemettilä, Jari-Pekka; Solismaa, Anssi; Seppälä, Niko; et al.

Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders

BMC Psychiatry, BioMed Central (BMC) 2021, Vol. 21, (1)

Leijala, J.; Kampman, O.; Suvisaari, J.; et al.

Impact of Comorbid Alcohol Use Disorder on Health-Related Quality of Life Among Patients With Depressive Symptoms

Frontiers in Psychiatry, Frontiers Media S.A. 2021, Vol. 12

Luoto, Kaisa E.; Lindholm, Lars H.; Koivukangas, Antti; et al.

Reaction time and visual memory in connection to hazardous drinking polygenic scores in schizophrenia, schizoaffective and bipolar disorder

Brain Sciences, MDPI 2021, Vol. 11, (11)

Mazumder, Atiqul Haq; Barnett, Jennifer; Isometsä, Erkki Tapio; et al.

Reaction time and visual memory in connection to alcohol use in persons with bipolar disorder

Brain Sciences, MDPI 2021, Vol. 11, (9)

Mazumder, Atiqul Haq; Barnett, Jennifer; Isometsä, Erkki Tapio; et al.

Reaction Time and Visual Memory in Connection to Hazardous Drinking Polygenic Scores in Schizophrenia, Schizoaffective Disorder and Bipolar Disorder.

Brain Sciences, Vol. 11, (11)

Mazumder, Atiqul Haq; Barnett, Jennifer; Isometsä, Erkki Tapio; et al.

Reaction time and visual memory in connection with alcohol use in schizophrenia and schizoaffective disorder

Brain Sciences, MDPI 2021, Vol. 11, (6)

Mazumder, Atiqul Haq; Barnett, Jennifer; Lindberg, Nina; et al.

Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorder

Brain and Behavior, John Wiley & Sons 2021, Vol. 11, (8)

Sorri, Annamari; Järventausta, Kaija; Kampman, Olli; et al.

Importance of congruence between communicating and executing implementation programmes: a qualitative study of focus group interviews

Implementation Science Communications, BioMed Central (BMC) 2020, Vol. 1, (1)

Lindholm, Lars H.; Laitila, Minna; Lassila, Antero; et al.

Journal of Clinical Psychopharmacology, Lippincott Williams & Wilkins 2020, Vol. 40, (3) : 293-296

Rask, Susanna Maria; Luoto, Kaisa E.; Solismaa, Anssi; et al.

SERT and NET polymorphisms, temperament and antidepressant response

Nordic Journal of Psychiatry, Vol. 69, (7) : 531-538

Andre, Kadri; Kampman, Olli; Illi, Ari; et al.

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: Susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

Neuroscience Letters, Vol. 590 : 116-120

Kautto, Mervi; Kampman, Olli; Mononen, Nina; et al.

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

European Archives of Psychiatry and Clinical Neuroscience, Vol. 261, (2) : 95-102

Illi, Ari; Poutanen, Outi; Setala-Soikkeli, Eija; et al.

View publications in DiVA

Professor Kampman’s teaching covers the following topics:

Medicine licentiate program:

Psychoses -diagnostics and treatment

Psychosocial interventions in the treatment of psychoses

Logopaedics program:

Substance related disorders